China News Service, November 3rd. Recently, the joint research results of Fudan University Cancer Hospital and Huami Technology (NYSE:HMI): "Wearable device-based lifestyle intervention for patients with stage I-III breast cancer Ingredient impact", published in Frontiers in Oncology.
The research relies on smart wearable technology and health cloud services to provide comprehensive interventions for patients after breast cancer surgery, effectively helping patients control weight, improve body composition, and reduce body fat, thereby improving prognosis and reducing the risk of disease recurrence, metastasis and death .
Breast cancer is the most common malignant tumor in women. The number of new breast cancer patients worldwide exceeds 2 million cases each year.
Thanks to advances in breast cancer screening technology and treatment technologies in recent years, the survival rate of breast cancer patients has been greatly improved. The five-year survival rate of Chinese women with breast cancer has reached 83.2%, while five of the five patients diagnosed and treated in the Cancer Hospital of Fudan University The annual survival rate is more than 90%.
The improvement of survival rate makes people's survival of breast cancer patients not only focus on living longer, but also on living better.
Previous studies have shown that breast cancer patients who are overweight, especially obese breast cancer patients, have a higher risk of death. Every 5kg/m2 increase in body mass index (BMI) increases the risk of death by 17%.
This study selected postoperative patients with breast cancer stage I-III who were treated in the Cancer Hospital of Fudan University.
A baseline survey of their diet, body composition, and quality of life found that although 65% of patients had a BMI within the normal range, 71.68% of patients had a body fat rate of more than 30%, and 41.59% of patients had lower skeletal muscle mass. low.
The study conducted comprehensive interventions by allowing subjects to wear smart bracelets equipped with health cloud services, combined with online and offline synchronized diet and exercise guidance.
It was found that after 3 months of the intervention, the body composition of the subjects had considerable changes: body weight, BMI, fat mass, body fat rate, basal metabolic rate and visceral fat area all decreased significantly.
Among them, the most obvious is the area of visceral fat, the average value dropped from 91.01cm2 in the baseline study to 84.15cm2.
The significant decline in these indicators all show the improvement of the patient's body composition and local microenvironment, and these improvements can reduce the risk of disease recurrence, metastasis and death in these patients in the future.
The corresponding author of the paper, Professor Zheng Ying, director of the Cancer Prevention Department of Fudan University Cancer Hospital, said that with the rapid development of information technology, the demand for refined management of cancer patients throughout the rehabilitation process has increased, and smart wearable devices are used to personalize recovered patients. Lifestyle management will gradually become a trend.
This lifestyle intervention can be used not only for breast cancer, but also for other cancers, such as colorectal cancer, prostate cancer, and early cancer lung cancer. Most of these cancers can survive for a long time, and their prognosis is closely related to lifestyle.
Corresponding author of the paper, Zheng Ying, director of the Cancer Prevention Department of Fudan University Cancer Hospital
It is understood that intervention research based on smart wearable devices has only gradually emerged in recent years.
The Huami staff involved in the study said that traditional exercise interventions generally use exercise interventions under the telephone or interview, and exercise intensity is generally high, and some patients cannot tolerate them. Instead, they choose a comprehensive intervention method based on wearable devices and health cloud services. , Can greatly save manpower, material resources and time costs, and effectively cover more patients.
The research team also stated that in the future, it will continue to carry out national multi-center intervention studies on lifestyle intervention, patient prognosis-related biomarkers, and patient long-term prognosis effects.